Schedule 13G ownership disclosure
Axsome Therapeutics Inc
Security class unavailable · CUSIP: 05464T104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,685,622
- Percent of class
- 7.1300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-016587
- Form type
- SC 13G
- Filer
- Axsome Therapeutics, Inc.
- CIK
- CIK 1579428
- Filed
- Feb 09, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership